Need an investment idea? Check out S2O Stock Screener. It allows to generate a list of stocks of a particular interest in a matter of seconds!

Market Price

1.00 

-0.03 -2.9%

as of Nov 13 '18

52 Week Range:

0.68 1.28


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Hamilton Thorne Ltd., together with its subsidiary, Hamilton Thorne, Inc., develops, manufactures, and sells precision laser devices and advanced image analysis systems for living cell applications in the fertility, stem cell, and developmental biology research markets. The company offers clinical lasers, such as LYKOS and ZILOS-tk lasers, as well as clinical laser software and hardware for clinical assisted reproduction; and research lasers, including XYRCOS and XYClone lasers for stem cell research, gene targeting, knock out mouse production, SCNT, ICSI, IVF, and assisted hatching applications, as well as Stiletto lasers for isolation of cells of interest, ablation of unwanted cells, and precision scoring of cell colonies. It also provides clinical sperm analysis (CASA) products comprising IVOS II Clinical and CEROS II Clinical, as well as Human Motility II and Dimensions II Strict Morphology software to clinics, hospitals, and laboratories; animal and research CASA systems, and motility software packages; and various sperm analyzer options. In addition, the company offers sperm analysis accessories, such as Accu-beads+ for use in counting procedures in semen analysis; 2X-CEL disposable semen analysis slides; IDENT Stains for determining sperm motility and concentration; VIADENT stain to determine viable sperm count, concentration, and percentage from a motile sample; and MiniTherm Stage Warmer for CASA and manual sperm motility analysis. Further, it offers IMSI-Strict, an automated software solution for live sperm morphology under high magnification; Oosight imaging system for research purposes; and CIVA, a custom software to capture images/video and annotate. The company sells its products to pharmaceutical and biotechnology companies, fertility clinics, university research centers, and other commercial and academic research establishments worldwide. Hamilton Thorne Ltd. is based in Beverly, Massachusetts.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '08 Jan '09 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17
Equity (BVPS) -0.16
-0.22
-0.05
-0.07
-0.07
-0.06
0.05
0.18
growth rate 0.0% 0.0% 0.0% 0.0% 0.0% 100.0% 260.0%
Earnings BIT -1.86
-1.99
-1.95
-1.83
0.35
1.09
1.28
1.25
3.09
growth rate 0.0% 0.0% 0.0% 100.0% 215.8% 17.5% -2.8% 147.8%
Avg.PE -3.10
-3.30
-3.30
19.53
22.50
12.78
76.25
50.00
growth rate 0.0% 0.0% 100.0% 15.2% -43.2% 496.6% -34.4%
ROA -25.76
-63.73
-71.40
-72.16
-68.92
6.04
29.99
19.64
7.02
22.80
growth rate 0.0% 0.0% 0.0% 0.0% 100.0% 396.5% -34.5% -64.3% 224.8%
ROE -26.35
45.00
36.20
68.90
26.96
45.50
growth rate 100.0% -19.6% 90.3% -17.1% 68.8%
ROIC -28.25
11.55
28.65
growth rate 100.0% 148.1%
Cur. Ratio 28.33
1.90
1.41
1.29
0.88
1.15
2.06
3.56
1.68
1.71
growth rate -93.3% -25.8% -8.5% -31.8% 30.7% 79.1% 72.8% -52.8% 1.8%
Quick Ratio 28.33
1.45
1.04
0.82
0.57
0.66
1.59
3.11
1.24
1.28
growth rate -94.9% -28.3% -21.2% -30.5% 15.8% 140.9% 95.6% -60.1% 3.2%
Leverage 1.04
4.35
3.60
1.74
growth rate 22.7% -17.2% -51.7%
Balance Sheet Dec '08 Jan '09 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17
Acct.Receivable 0.56
1.12
1.12
0.89
0.63
0.97
1.21
1.64
2.73
growth rate 100.0% 0.0% -20.0% -29.7% 53.9% 25.2% 35.5% 66.8%
Acct.Payable 1.51
1.49
1.36
1.41
2.43
growth rate -1.3% -8.4% 3.9% 71.8%
Cur.Assets 2.79
2.57
2.68
2.01
1.87
3.30
6.30
4.72
11.31
growth rate -8.0% 4.4% -25.0% -6.8% 76.3% 90.9% -25.1% 139.6%
Total Assets 2.90
2.79
3.01
2.23
2.10
3.61
7.11
12.24
37.81
growth rate -3.8% 8.0% -25.9% -5.9% 71.9% 96.9% 72.3% 208.8%
Cash 1.56
0.78
0.56
0.45
0.45
1.58
4.29
1.84
5.74
growth rate -50.0% -28.6% -20.0% 0.9% 250.3% 172.4% -57.2% 212.5%
Inventory 0.56
0.56
0.89
0.67
0.70
0.64
0.66
1.13
2.42
growth rate 0.0% 60.0% -25.0% 4.9% -8.7% 2.3% 71.9% 114.9%
Cur.Liabilities 1.45
1.78
2.01
2.23
1.63
1.60
1.77
2.80
6.63
growth rate 23.1% 12.5% 11.1% -26.9% -2.1% 10.7% 58.4% 136.4%
Liabilities 7.14
8.81
6.14
6.25
5.45
5.40
5.47
8.84
16.13
growth rate 23.4% -30.4% 1.8% -12.8% -0.9% 1.5% 61.5% 82.5%
LT Debt 5.69
6.92
4.02
3.90
3.79
3.79
3.50
5.88
9.29
growth rate 21.6% -41.9% -2.8% -3.0% 0.1% -7.6% 68.0% 58.1%
Equity -3.73
-5.33
-2.75
-3.35
-1.79
1.63
3.40
21.68
growth rate 0.0% 0.0% 0.0% 0.0% 100.0% 108.4% 537.0%
Common Shares 3.00
18.00
24.00
31.00
50.00
52.00
57.00
69.00
75.00
109.00
growth rate 500.0% 33.3% 29.2% 61.3% 4.0% 9.6% 21.1% 8.7% 45.3%
Cash Flow Statement Dec '08 Jan '09 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17
Capital Expenditures 0.11
0.11
0.11
0.00
0.02
0.03
0.03
0.10
0.39
growth rate 0.0% 0.0% -100.0% 113.0% -26.0% 292.1% 290.2%
Cash Dividends 0.00 0.00 0.00
growth rate
Cash From OA -0.65
-1.68
-1.87
0.23
0.67
1.06
0.99
3.24
growth rate 0.0% 0.0% 100.0% 195.2% 58.1% -6.1% 227.5%
FCF per Share -0.04
-0.07
-0.08
-0.02
0.01
0.01
0.01
0.02
growth rate 0.0% 0.0% 0.0% 100.0% 0.0% 0.0% 100.0%
Sale Purchase of Stock 0.64
0.64
2.04
0.04
9.39
growth rate 0.0% 217.9% -98.1% 24,474.4%
FCF -1.00
-2.00
-2.00
-1.00
0.10
1.00
1.00
0.30
2.00
growth rate 0.0% 0.0% 0.0% 100.0% 900.0% 0.0% -70.0% 566.7%
Income Statement Dec '08 Jan '09 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17
Sales 5.35
6.92
8.03
7.03
7.48
8.71
9.03
10.51
22.12
growth rate 29.2% 16.1% -12.5% 6.4% 16.5% 3.8% 16.4% 110.4%
Op.Income -1.45
-1.67
-1.56
-1.45
0.35
1.09
1.28
1.25
3.09
growth rate 0.0% 0.0% 0.0% 100.0% 215.8% 17.5% -2.8% 147.8%
IBT 0.00
0.00
-2.12
-1.78
0.13
0.87
1.05
0.70
1.64
growth rate 0.0% 100.0% 595.1% 20.3% -33.4% 135.8%
Net Income -1.90
-2.01
-2.12
-1.78
0.13
0.86
1.03
0.68
5.71
growth rate 0.0% 0.0% 0.0% 100.0% 584.0% 20.0% -33.9% 740.6%
EPS -0.13
-0.10
-0.08
-0.06
-0.03
0.00
0.02
0.02
0.01
0.05
growth rate 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -50.0% 400.0%
Gross Profit 3.35
4.35
5.02
4.13
4.63
5.55
5.76
6.86
13.18
growth rate 30.0% 15.4% -17.8% 12.1% 19.9% 3.8% 19.1% 92.1%
R&D 0.89
1.12
1.34
1.12
0.84
0.91
0.97
0.99
1.54
growth rate 25.0% 20.0% -16.7% -25.1% 9.4% 6.2% 1.9% 55.9%

Quarterly Statements

Item Name Jun '17 Sep '17 Dec '17 Mar '18 Jun '18
Earnings BIT 1.01
0.92
0.62
1.02
1.00
growth rate -8.2% -33.2% 64.4% -1.3%
Balance Sheet Jun '17 Sep '17 Dec '17 Mar '18 Jun '18
Acct.Receivable 2.50
2.48
2.73
2.71
2.66
growth rate -0.5% 10.0% -0.8% -2.0%
Acct.Payable 2.74
2.34
2.43
2.74
2.82
growth rate -14.8% 3.9% 12.6% 3.2%
Cur.Assets 10.46
10.74
11.31
12.31
12.86
growth rate 2.7% 5.3% 8.9% 4.5%
Total Assets 31.76
31.95
37.81
38.90
38.69
growth rate 0.6% 18.4% 2.9% -0.6%
Cash 5.31
5.35
5.74
5.86
6.28
growth rate 0.9% 7.3% 2.0% 7.1%
Inventory 2.38
2.56
2.42
3.05
3.34
growth rate 7.8% -5.4% 25.8% 9.5%
Cur.Liabilities 7.20
6.77
6.63
6.47
7.07
growth rate -5.9% -2.2% -2.3% 9.2%
Liabilities 17.01
16.27
16.13
15.71
15.81
growth rate -4.4% -0.8% -2.6% 0.6%
LT Debt 9.66
9.35
9.29
9.03
8.50
growth rate -3.2% -0.6% -2.9% -5.8%
Equity 14.75
15.68
21.68
23.19
22.88
growth rate 6.3% 38.2% 7.0% -1.3%
Common Shares 42.42
42.45
42.15
42.16
42.65
growth rate 0.1% -0.7% 0.0% 1.2%
Cash Flow Statement Jun '17 Sep '17 Dec '17 Mar '18 Jun '18
Capital Expenditures 0.07
0.16
0.14
0.06
0.03
growth rate 111.4% -13.7% -54.6% -45.1%
Cash From OA 0.30
0.66
1.23
0.75
0.98
growth rate 121.8% 87.5% -39.1% 30.4%
Sale Purchase of Stock 8.48
0.03
0.87
0.01
growth rate -99.6% 2,527.9% -99.0%
FCF 0.22
0.50
1.09
0.69
0.94
growth rate 125.3% 119.5% -37.1% 37.2%
Income Statement Jun '17 Sep '17 Dec '17 Mar '18 Jun '18
Sales 5.60
6.05
7.18
7.00
7.30
growth rate 8.0% 18.6% -2.5% 4.3%
Op.Income 1.01
0.92
0.62
1.02
1.00
growth rate -8.2% -33.2% 64.4% -1.3%
IBT 0.08
0.71
0.45
1.13
0.10
growth rate 755.6% -36.7% 153.6% -91.5%
Net Income 0.03
0.61
4.66
0.89
-0.13
growth rate 1,899.7% 658.6% -80.8% -100.0%
EPS
growth rate
Gross Profit 3.39
3.64
3.92
3.94
4.14
growth rate 7.4% 7.6% 0.6% 5.1%
R&D 0.33
0.45
0.48
0.44
0.41
growth rate 36.1% 7.4% -9.9% -6.6%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

A+ (93.55)

YOY Growth Grade:

D (41.68)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 21.74 21.74 33.33
EPS / Growth 0.0% 0.05

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 50.0%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 0.0% 25.0% 50.0%
Future PE 0.00 35.02 51.69
Future EPS 0.05 0.43 2.65
Value Price
MOS %
0.00
-100.0%
3.71
270.9%
33.89
3,289.3%
MOS Price 0.00 1.85 16.95
IRT 21.74 7.49 5.17

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.